Codar
Loading...Codar Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Do not exceed recommended dosage.
- if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
- a cough that lasts or is chronic such as occurs with smoking, asthma or emphysema
- a cough that occurs with too much phlegm (mucus)
- chronic pulmonary disease or shortness of breath or children who are taking other drugs
- heart disease
- high blood pressure
- thyroid disease
- diabetes mellitus
- difficulty in urination due to an enlarged prostate gland
- nervousness, dizziness, or sleeplessness occur
- cough or nasal congestion persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache. These could be signs of a serious condition.
- new symptoms occur
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
- cough due to minor throat and bronchial irritation
- nasal congestion
- reduces swelling of nasal passages
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Codar Manufacturers
-
Respa Pharmaceuticals
![Codar (Codeine Phosphate, Pseudoephedrine Hydrochloride) Liquid [Respa Pharmaceuticals]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Codar | Respa Pharmaceuticals
Do not exceed recommended dosage. Adults and Children
12 years of age and
over:
2 teaspoonfuls (10 mL)
every 4-6 hours, not to
exceed 8 teaspoonfuls
in a 24 hour period.
Children 6 to under
12 years of age:
1 teaspoonful (5 mL)
every 4-6 hours, not to
exceed 4 teaspoonfuls
in a 24 hour period.
Children under 6
years of age:
Not recommended
for use.
Login To Your Free Account